Navigation Links
Phalanx Biotech Group Announces CytoOneArray®, a Targeted Chromosomal Microarray
Date:5/8/2012

BELMONT, Calif., May 8, 2012 /PRNewswire/ -- Phalanx Biotech Group, a global genomic products and service provider, announces today the completion of manufacturing and testing for a proprietary targeted chromosomal microarray (CMA) designed specifically for prenatal and postnatal detection of microdeletions and microduplications related to a spectrum of congenital disorders, especially developmental and intellectual delay disorders. CytoOneArray® is capable of detecting 264 clinically confirmed disease regions and 41 subtelomere regions.

"Extensive testing from our CytoOneArray® manufacturing campaign demonstrates a quality product with high sensitivity, robustness, and reproducibility. We are extremely excited about offering our focused CMA at the time when cytogeneticists are adopting chromosomal microarray as a first-tier clinical diagnostic test," said Shengwan Lee, Ph.D., President and CEO. "As the first in a series of CMA microarrays, Phalanx will continue to expand its line of clinical diagnostic products by leveraging its high performance microarray technology and innovative manufacturing processes."

CytoOneArray® resulted from extensive collaborations between leading cytogeneticists in Taiwan and Phalanx Biotech Group.  Through a comprehensive curation process of current, peer-reviewed and clinically confirmed disease regions, the Phalanx team designed probes to cover 90% of published microdeletions and microduplications associated with developmental and intellectual delay disorders. 

About Phalanx Biotech Group

Phalanx Biotech Group, with operations in California, Taiwan and China, provides genomics research products and services worldwide to academic, clinical, pharmaceutical and biotech communities. Built on world-class, integrated-chip foundry technology, Phalanx Biotech has developed the OneArray® line of high-quality and affordable microarrays for expression profiling of whole genomes (human, mouse, rat, yeast and rice), microRNA (human, mouse, rat and plants), and custom targets.  Our highly-trained service specialists provide a comprehensive offering of gene expression and microRNA expression profiling services for biomarker discovery including sample preparation, expression analysis, and qPCR validation. For more information about our products and services, please visit our website at www.OneArray.com.

Contact
Vivien Mak, Ph.D., 1-650-320-8669 ext 103
vmak@onearray.com


'/>"/>
SOURCE Phalanx Biotech Group
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Phalanx Biotech Group Launches Rice Genome OneArray®
2. Phalanx Biotech Group Reports Robust Revenue Growth in 2011
3. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
4. Yongye Biotechnology International Retains CCG Investor Relations
5. ThirdBiotech Announces Kemeta as Newest Sponsor
6. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
7. Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN(R)/Docetaxel Trial
8. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
9. Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results
10. China Kangtai Cactus Biotech Announces Record Second Quarter Results
11. Yongye Biotechnology International Announces Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... , Feb. 5, 2016 Australian-US drug discovery ... announced today the appointment of a new Chairman, Mr ... Carmine , effective immediately. James Garner , ... Executive Director and former Acting CEO, Mr Iain Ross ... Non-Executive Director. --> James Garner , has also ...
(Date:2/4/2016)... Falls Church, VA (PRWEB) , ... ... ... a first-year cybersecurity conference presented by Bloomsburg University’s Digital Forensics Club, takes ... Bloomsburg, PA. The two-day event features 20+ speakers and activities such as ...
(Date:2/4/2016)... ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), ... of targeted antiviral therapies, announced today that it will ... be held February 8-9, 2016, at the Waldorf Astoria ... & Healthcare Conference, taking place in New ... James Sapirstein , Chief Executive Officer of ContraVir, will ...
(Date:2/4/2016)... ... , ... Many of the engineers at FireflySci, Inc. have been manufacturing quartz ... from other cuvette manufacturers is their supercharged customer service and their extensive database of ... steady flow of inside information, they have recently revamped their manufacturing techniques to reduce ...
Breaking Biology Technology:
(Date:2/3/2016)... , Feb. 3, 2016 ... the addition of the "Emotion Detection ... Machine Learning, and Others), Software Tools (Facial ... Areas, End Users,and Regions - Global forecast ... --> http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has ...
(Date:2/2/2016)... 2, 2016   Parabon NanoLabs (Parabon) ... Army Research Office and the Defense Forensics and ... of the company,s Snapshot Kinship Inference ... more generally, defense-related DNA forensics.  Although Snapshot is ... appearance and ancestry from DNA evidence), it also ...
(Date:1/28/2016)... Jan. 28, 2016 Synaptics (NASDAQ: SYNA ), a ... its second quarter ended December 31, 2015. ... of fiscal 2016 increased 2 percent compared to the comparable quarter ... of fiscal 2016 was $35.0 million, or $0.93 per diluted share. ... income for the first quarter of fiscal 2016 grew 9 percent ...
Breaking Biology News(10 mins):